Bioptimus announces a $76M funding milestone, with the latest injection of $41M led by Cathay Innovation less than 12 months from its initial seed round Since the successful release of the largest AI ...
In an interview with VentureBeat, Jean-Philippe Vert, co-founder and CEO of Bioptimus, chief R&D Officer of Owkin and former research lead at Google Brain, said as a smaller, independent company, ...
Partnership aims to accelerate precision immunotherapy by leveraging AI-powered virtual cell models to identify which patients are most likely to benefit from BOT/BAL treatment Collaboration builds on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results